Versigent PLC (VGNT)
NYSE: VGNT · Real-Time Price · USD
43.39
-0.48 (-1.09%)
Oct 21, 2026, 4:00 PM EDT - Market closed
Versigent Revenue
Versigent had revenue of $2.44B in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $9.24B. In the year 2025, Versigent had annual revenue of $8.82B with 6.13% growth. That makes Versigent the 1,571st largest company in the world by revenue and 482nd in the United States.
Revenue (ttm)
$9.24B
Revenue Growth
+6.13%
P/S Ratio
0.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.07B
Revenue by Geography
- United States 3.57B 40.5%
- Asia Pacific 2.90B 32.9%
- Europe, Middle East & Africa (Excl. Germany) 1.37B 15.5%
- Germany 709.00M 8.0%
- South America 276.00M 3.1%
Fiscal year ended Dec 31, 2025 See the full Versigent breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.82B | 509.00M | 6.13% |
| Dec 31, 2024 | 8.31B | -523.00M | -5.92% |
| Dec 31, 2023 | 8.83B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
VGNT News
- 9 days ago - Versigent price target raised to $53 from $52 at RBC Capital - TheFly
- 16 days ago - Versigent price target lowered to $58 from $59 at Goldman Sachs - TheFly
- 20 days ago - Versigent Announces Third Quarter 2026 Earnings Call Details - Business Wire
- 2 months ago - Versigent price target raised to $54 from $50 at Argus - TheFly
- 2 months ago - Versigent price target raised to $65 from $60 at Evercore ISI - TheFly
- 2 months ago - Versigent downgraded to Equal-Weight from Outperform at Fox Advisors - TheFly
- 2 months ago - Versigent price target raised to $58 from $49 at TD Cowen - TheFly
- 2 months ago - Versigent price target raised to $54 from $50 at Deutsche Bank - TheFly